A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
Running, not enrolling · Phase 2 · Has a placebo group
Conditions studied: Focal Epilepsy
In brief
The XEN1101 Phase 2 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of increasing doses of XEN1101 administered as adjunctive treatment in adult patients diagnosed with focal epilepsy, followed by an optional open-label extension (OLE).
Key facts
- Study ID
- NCT03796962
- Run by
- Xenon Pharmaceuticals Inc.
- People needed
- 325
- Starts
- 2019-01-30
- Expected to finish
- 2028-10-01
- Last updated by the study team
- 2024-09-24
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Strada Patient Care Center — Mobile, Alabama, United States
- Xenoscience, Inc. — Phoenix, Arizona, United States
- Clinical Trials, Inc. — Little Rock, Arkansas, United States
- Altman Clinical Translational Research Institute (ACTRI) — La Jolla, California, United States
- California Pacific Medical Center (CPMC) - Sutter Pacific Epilepsy Program — San Francisco, California, United States
- University of Colorado Hospital Anschutz Outpatient Pavilion — Aurora, Colorado, United States
- University of Florida Jacksonville — Jacksonville, Florida, United States
- Mayo Clinic Florida — Jacksonville, Florida, United States
- Visionary Investigators Network — Miami, Florida, United States
- Don Clinical Research Center — Miami, Florida, United States
- The Neurology Research Group, LLC. — Miami, Florida, United States
- Research Institute of Orlando, LLC — Orlando, Florida, United States
- Medsol Clinical Research Center — Port Charlotte, Florida, United States
- Tallahassee Neurological Clinic — Tallahassee, Florida, United States
- University of South Florida — Tampa, Florida, United States
- Georgia Neurology and Sleep Medicine Associate — Suwanee, Georgia, United States
- Hawaii Pacific Neuroscience — Honolulu, Hawaii, United States
- Consultants in Epilepsy and Neurology, PLLC — Boise, Idaho, United States
- Northwestern Medical Group, Department of Neurology — Chicago, Illinois, United States
- University of Kansas Medical Center — Kansas City, Kansas, United States
- Bluegrass Epilepsy Research — Lexington, Kentucky, United States
- Maine Medical Partners Neurology — Scarborough, Maine, United States
- Mid-Atlantic Epilepsy and Sleep Center — Bethesda, Maryland, United States
- Boston Neuro Research Center — South Dartmouth, Massachusetts, United States
- University of Alabama at Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.